AH

Anwar Hussain Raees Ahmed Ansari

Active Director Designated Partner DIN 10206414
DIN 10206414 First appointment Jun 2023 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Anwar Hussain Raees Ahmed Ansari

Data last updated:

Anwar Hussain Raees Ahmed Ansari is a Designated Partner at Crysta Pharmatech Llp (since 2023). The company operates in Business Services.

DIN 10206414
Primary Designation Designated Partner
Industry Business Services
First Appointment 19 Jun 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner19 Jun 20232023Active

Board colleagues of Anwar Hussain Raees Ahmed Ansari

NameDINCompanyDesignation
Imamul Haq Abbas Shaikh07314157Crysta Pharmatech LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Crysta Pharmatech Llp
Premium access

Shareholding and investment profile for Anwar Hussain Raees Ahmed Ansari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anwar Hussain Raees Ahmed Ansari

Anwar Hussain Raees Ahmed Ansari currently holds 1 directorship: Crysta Pharmatech Llp (Designated Partner, since 19 Jun 2023).

Anwar Hussain Raees Ahmed Ansari was first appointed on 19 Jun 2023 as Designated Partner at Crysta Pharmatech Llp.

The current boards of Anwar Hussain Raees Ahmed Ansari's companies include Imamul Haq Abbas Shaikh (Crysta Pharmatech Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available